Compounding Pharmacists Get Peptide Breathing Room While Rules Catch Up
Published Date: 10/30/2026
Notice
Summary
HHS is giving pharmacists and doctors a green light to keep using certain peptide ingredients for making custom medicines while they work on official rules. This helps patients get personalized treatments without delays, but the agency will keep an eye on safety. Comments on this policy are open for two weeks after October 30, 2026, so stakeholders can weigh in.
Analyzed Economic Effects
3 provisions identified: 1 benefits, 1 costs, 1 mixed.
Temporary Green Light for Peptide Compounding
HHS says it does not intend to take enforcement action against a State-licensed pharmacy, a Federal facility, or a licensed physician that compounds drug products using the peptide bulk drug substances listed in Appendix A while the 503A bulks list is developed through rulemaking. The notice was published October 30, 2026, and applies only to peptides specifically listed in Appendix A of the Enforcement Discretion Policy.
Policy May Be Reversed If Safety Issues Arise
HHS states it may revisit or change this interim enforcement policy (in whole or in part) if a safety signal or product quality issue arises with a compounded drug product within the scope of this policy. That means patient access enabled by the policy could be reduced or removed if safety or quality problems occur.
Future Rulemaking Could Formalize Peptide Status
HHS notes that FDA's future rulemakings may propose adding some or all of the peptides listed in Appendix A to the 503A bulks list under section 503A of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 353a). Any such additions would be determined through future rulemaking based on available evidence.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-21943, Health Data, Technology, and Interoperability: ONC Deregulatory Actions To Unleash Prosperity
Starting December 28, 2026, new rules will make health tech easier and less costly for developers and healthcare providers by cutting red tape and updating certification standards. These changes help speed up innovation and improve how health data moves between systems, benefiting patients and the industry alike. Some updates kick in January 1, 2027, so everyone has time to adjust and thrive.
2026-21420, Medicare Program; Implementation of Sections 6219, 6220, and 6224 of the Consolidated Appropriations Act, 2026
This new Medicare rule will help people with low incomes pay less for their prescriptions, make sure health provider lists are accurate, and hold pharmacy benefit managers more accountable. If you use Medicare Part D or work with pharmacies and providers, these changes could affect you starting soon. Comments on the rule are open until December 15, 2026, so now’s the time to speak up!
2026-20848, Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods
The FDA is changing food rules to allow salt substitutes in many standardized foods, helping companies make lower-sodium options. This move aims to cut heart disease risks by reducing sodium without changing how foods basically taste or look. The new rule kicks in December 14, 2026, and food makers have until November 12, 2026, to raise any concerns, with no big costs expected.
2026-20447, Transparency in Coverage
Starting soon, health plans and insurers must share clearer, easier-to-understand price info for medical services and drugs. This helps you see what in-network and out-of-network costs really look like, with more details and better updates. These changes affect most group and individual health plans and kick in with new reporting rules to make healthcare pricing more transparent and fair.
2026-20281, Global Benchmark for Efficient Drug Pricing (GLOBE) Model
Starting November 30, 2026, Medicare will use the new GLOBE Model to help lower the cost of certain drugs for people on Original Medicare. This model changes how drug price increases are calculated, aiming to save money for both patients and the Medicare program without cutting care quality. If you’re on Medicare Part B, expect smarter drug pricing that helps keep your healthcare affordable.
2026-20131, Medicare Program; Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2027 and Updates to the IRF Quality Reporting Program; Correction
This correction fixes some technical mistakes in the Medicare payment rules for inpatient rehab facilities starting October 1, 2026. It mainly affects hospitals and rehab centers by clarifying how wage data and payments are calculated, ensuring fairer payment rates for fiscal year 2027. No big changes in money, but it keeps everything accurate and on track.
Previous / Next Documents
Previous: 2026-22191, Railway Tank Cars and Parts Thereof From Mexico; Revised Schedule for the Subject Investigations
The U.S. International Trade Commission is updating the timeline for investigating railway tank cars and parts from Mexico because the Department of Commerce extended its deadline. This change affects companies involved in importing or exporting these tank cars, giving everyone a bit more time before decisions and possible tariffs kick in. Expect the Commission’s preliminary findings shortly after Commerce’s new deadline of November 9, 2026.
Next: 2026-22193, Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request; DOCX Submission Requirements
The United States Patent and Trademark Office (USPTO) is asking for public feedback on its DOCX submission rules, which affect anyone filing patent applications. They want to make sure the process is smooth and not too much work for applicants. Comments are open until November 30, 2026, so don’t miss your chance to weigh in!